title: Lignosulfonic acid blocks in vitro fertilization of macaque oocytes when sperm are treated either before or after capacitation.
abstract: Lignin-derived macromolecules (LDMs) are biologically active compounds that affect a variety of cell-to-cell interactions including the inhibition of fertilization and embryo development in a number of nonmammalian species. The effect of ligno-sulfonic acid (LSA), a highly sulfonated LDM, on cynomolgus macaque sperm-oocyte interaction was evaluated with a zona pellucida binding assay and by in vitro fertilization (IVF). Sperm were treated with LSA (1.5 mg/mL) either before washing or after capacitation. Capacitation included centrifugation through 80% Percoll followed by 2 consecutive washes with medium, overnight incubation, and activation with dibutyryl cyclic adenosine monophosphate and caffeine. The zona binding assay was performed using immature oocytes that had adhered to the center of glass "binding chambers." The number of capacitated sperm that attached to the zona over a 3-minute period was recorded. Sperm attachment was significantly inhibited by LSA as compared to controls whether treatment occurred after capacitation (92.5%; P <.001) or before washing (82.5%; P <.001). When sperm were treated similarly with fucoidin, a sulfated polysaccharide known to inhibit sperm-oocyte interaction, sperm-zona binding was significantly inhibited by postcapacitation treatment but not by prewash treatment. Treatment of sperm with LSA consistently blocked fertilization over 4 IVF cycles both before washing and after capacitation. Fertilization rate for controls was 65% +/- 17%. No LSA-treated sperm were observed on the surface of lightly rinsed oocytes after 4 hours of coincubation. Localization of biotinylated LSA showed labeling over the entire sperm surface with the greatest intensity observed over the head and midpiece. LSA treatment had no effect on the percentage of motile sperm or quality of sperm motility. Due to the antifertility properties of this nontoxic molecule, LSA appears to have potential as a vaginal contraceptive.
authors.affiliation: Division of Reproductive Biology, Department of Obstetrics and Gynecology, University of California, Davis, 94923, USA.
authors.forename: Theodore L
authors.initials: TL
authors.lastname: Tollner
authors.forename: James W
authors.initials: JW
authors.lastname: Overstreet
authors.forename: Ming W
authors.initials: MW
authors.lastname: Li
authors.forename: Stuart A
authors.initials: SA
authors.lastname: Meyers
authors.forename: Ashley I
authors.initials: AI
authors.lastname: Yudin
authors.forename: Edward R
authors.initials: ER
authors.lastname: Salinas
authors.forename: Gary N
authors.initials: GN
authors.lastname: Cherr
mesh_terms: D000818:Animals; D004334:Drug Administration Schedule; D005260:Female; D005306:Fertilization / Q000187:drug effects*; D005307:Fertilization in Vitro; D008031:Lignin / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D008252:Macaca fascicularis; D008297:Male; D009865:Oocytes / Q000502:physiology*; D013075:Sperm Capacitation; D013084:Sperm-Ovum Interactions; D013094:Spermatozoa / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D014018:Tissue Distribution; D015044:Zona Pellucida / Q000502:physiology
chemical_list: C001545:lignosulfuric acid; D008031:Lignin